PHYSIOLOGY AND IMAGING: WHY ALL THIS IS IMPORTANT

Prof Andrew Sharp qualified from Edinburgh Medical School in 1998 and is Professor of Cardiology at the University Hospital of Wales and Cardiff University in the U.K. He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training. He completed the prestigious Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus Hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo. He also spent three years training in interventional cardiology at Imperial College Hospitals in London. Prof Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his research interests include intracoronary imaging and physiology. as well as the use of device-based treatments for hypertension and pulmonary embolism.

Angela McInerney is an Interventional Cardiologist at University Hospital Galway, Ireland. Following completion of her basic cardiology training in Ireland she was awarded the Brian McGovern Travelling Fellowship grant from the Irish Board for Cardiology Training in 2018 which allowed her to start her interventional fellowship in Hospital Clínico San Carlos, Madrid, Spain. Following two years of coronary training including complex PCI, she was awarded an European Society of Cardiology Fellowship Training Grant and completed a further year of structural intervention also in Clínico San Carlos, Madrid. Her specialist interests are in intracoronary imaging, intracoronary physiology, calcium modification techniques and complex PCI. She has been keenly involved in various research projects pertaining to intracoronary physiology and intravascular imaging having authored and co-authored a number of research articles as well as review articles and book chapters on these topics. During her fellowship she also regularly partook in the preparation and delivery of educational courses in Clínico San Carlos and values the educational aspect of her role as a Consultant Interventional Cardiologist.

Dr Carlos Collet completed his education as an interventional cardiologist at the prestigious Dante Pazzanese Institute of Cardiology in Sao Paulo, Brazil 2011, with training in cardiac CT at the Holy Cross Hospital, Florida, USA. Dr. Collet Bortone continued his education with a doctorate in cardiovascular sciences at the University of Amsterdam, and his Ph.D. thesis focused on the expansion of the current indication of cardiac CT to patients with complex coronary artery disease. Dr. Collet Bortone has published more than 300 peer-reviewed articles, and his research focused on the integration of cardiac imaging and physiology. He is the co-director of the catheterisation laboratory at the OLV Hospital in Aalst, Belgium.

Dr Justin Davies is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and an interventional cardiologist with over 15 years of experience as a leading educator in the field. His clinical and academic career was established at Hammersmith Hospital, Imperial College London, where he built an international reputation for innovation in cardiovascular medicine. Over the course of his career, he has successfully mentored 15 PhD students, published more than 500 peer-reviewed papers — including landmark studies in the New England Journal of Medicine and The Lancet — and holds 20 patents in cardiovascular medicine and technology. He was the co-principal investigator of the DEFINE-FLAIR study, which helped establish iFR (Instantaneous Wave-Free Ratio), a diagnostic technique he invented, as a globally adopted standard in coronary physiology. His work reflects a unique blend of scientific innovation, academic leadership, and clinical excellence. In addition to his research and academic commitments, Justin is CEO of Cerebria AI, where he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools. Under his leadership, Cerebria AI is advancing cutting-edge solutions that integrate artificial intelligence with frontline cardiology to enhance clinical decision-making and patient outcomes. Combining deep clinical expertise with entrepreneurial vision, he continues to guide international ventures through funding, regulatory pathways, and commercialization, while remaining committed to transforming cardiovascular care on a global scale.

Dr. Salvatore Brugaletta is a Senior Consultant Interventional Cardiologist with a large experience in coronary and structural heart disease (Intracoronary imaging, INOCA, complex heart disease, left main, bifurcation, STEMI, cardiogenic shock, TAVI, etc). Highly skilled in Clinical Research, Medical Education and Medical Devices with strong commitment inside medical communities. Two PhD focused on interventional cardiology from Erasmus University (Rotterdam, The Netherlands) and Sacred Heart University (Rome, Italy). He has authored around 380 manuscripts published in the peer-reviewed literature. Clinically, his interests include: preventive cardiology, acute coronary syndrome / angina, drug eluting metallic and bioresorbable stents, invasive coronary imaging and physiology and TAVI (Transcatheter aortic valve implantation).